Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.
about
Doublet Versus Single Agent as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis of 10 Randomized Controlled TrialsPhase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis.Efficacy of S-1 monotherapy for non-small cell lung cancer after the failure of two or more prior chemotherapy regimens.Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials.Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.Efficacy of S-1 in non-small cell lung cancer.Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancerAdverse events risk associated with anti-VEGFR agents in the treatment of advanced nonsmall-cell lung cancer: A meta-analysis.
P2860
Q26764802-68B2887E-9BAE-4446-878F-55B856D28B91Q33387184-18B925D0-1000-4BAD-91F1-00229FD6FF4EQ33403640-EC6113C9-A56E-460B-A259-46FE18D4D96CQ33631305-9AD2926B-08D8-4754-85E5-A12BB67909ADQ36217041-45D58C05-628D-4855-9C39-85C7A1F97005Q36281513-9E001222-EBF1-48E3-BFFB-F9FF4B62DFAFQ38133562-7C7064A9-4FA7-48B5-97FD-798FE102BA78Q38238511-DDBD09F1-8526-46BD-A01D-F6CA11B5A19DQ40273851-3508FD06-612B-4CD8-ADB2-3D744533B65CQ40979235-9124EEAC-08EC-4CF5-98D8-BFFBB5F9D31BQ42359608-20EE99FA-0F0C-4662-BD4E-5CFDB90B4C2B
P2860
Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@ast
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@en
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@nl
type
label
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@ast
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@en
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@nl
prefLabel
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@ast
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@en
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@nl
P2093
P356
P1476
Early phase II study of S-1, a ...... ed non-small-cell lung cancer.
@en
P2093
K Hasegawa
M Kawahara
S-1 Cooperative Study Group (Lung Cancer Working Group)
Y Ichinose
P2888
P304
P356
10.1007/PL00012111
P577
2001-10-01T00:00:00Z